The Progress of Research in Molecular Structure and Function of Histone Deacetylase 6

Xiaoyan Zhu; Wenke Zhou

doi:10.54097/ijbls.v3i3.08

Authors

Xiaoyan Zhu
Wenke Zhou

DOI:

https://doi.org/10.54097/ijbls.v3i3.08

Keywords:

Histone Deacetylase 6, HDAC6 Inhibitor, Drosophila Longevity, Tumor

Abstract

Histone deacetylases (HDACs) family play an important role in the regulation of cell expression. Histone deacetylase (HDAC) 6 is a special member of the family of histone deacetylases proteins. The specific molecular structure of histone deacetylase 6 determines that HDAC6 can specifically deacetylate non-histone proteins and their substrates, and regulate cell growth, metastasis and apoptosis. However, numerous studies have shown that HDAC6 does have a significant impact on certain diseases, such as cancer, central nervous system diseases, etc. Some studies have even found that HDAC6 may extend life span. This paper mainly talks about the structure and function of HDAC6 from several aspects, including the molecular structure of histone deacetylase 6, the effect of HDAC6 inhibitor, the effect of histone deacetylase 6 on Drosophila longevity and the effect of HDAC6 on nervous diseases. Hoping the introduction of this paper can let people understand HDAC6 so that more researchers can pay attention to HDAC6 and do some studies about it, and then lead to more and better research results.

Downloads

Download data is not yet available.

References

Li Bin, Wang Jiming. Histone deacetylase 6 (HDAC6) and tumor. Journal of Clinical and Experimental Medicine, 2006, 5(4).

Shi Xuhan, Wei Wenbin. Characteristics and application of HDAC6 inhibitors. Chinese Journal of Medical Frontiers, 2017,9(2).

Chen Guozhen, Tian Jie. Histone acetylase and deacetylase and embryonic development. International Journal of Reproductive Health, 2008.

Han Yuting, Xu Bowen, Li Yutong, et al. Frontier Techniques for Gene Regulation of Model Animal Drosophila. Genetics, 2022,44(1).

Deng Fangjing, Zhu Jeff, Wu Xiongfei. Inhibition of HDAC6 can enhance autophagy and alleviate renal ischemia reperfusion injury. Journal of Medical Research, 2022,52(10).

Yingxiu Li,Donghee Shin,So Hee Kwon.Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes [J]. FEBS Journal, 2012.

Wendy, Yu Xiujun, Guo Yansu. Histone deacetylase and autophagy [J]. Shandong Pharmaceutical, 2011.

Bertos NR, Gilquin B, Chan GK, et al.Role of the tetradecapeptide repeat domain of human histone deacetylase6 in cytoplasmic retention. J Biol Chem,2004,279(46).

Hideshima T,Bradner JE,Wong J,et al.Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor actitumor activity in multiple myeloma. Prac Natl Acad Sci U S A,2005,102(24).

Kawaguchi Y, Kovacs JJ, Mclaurin A,et al.The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.Cell, 2003, 115 (6).

Nawrocki ST,Carew JS,Pion MS,et al.Aggresome disruption:a noval strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.Cancer Res,2006,66(7).

Gong Shuwen, Shen Shuijuan, Zhang Sumei, et al. Study on the inhibitory effect of HDAC6 inhibitors on lupus nephritis in mice. Modern Practical Medicine, 2019.

Wang N, Bartlow P, Ouyang Q,et al.Recent advances in antimultiple myeloma drug development.Pharm Pat Anal, 2014, 3(3).

Haggarty SJ, Koeller KM, Wong JC,et al.Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediate dtubulin deacetylation. Proc Natl Acad Sci USA, 2003,100(8).

Butler KV, Kalin J, Brochier C, et al.Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A.J Am Chem Soc,2010,132(31).

Watson GW,Wickramasekara S,FangY,et al.HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells.Exp Biol Med(Maywood),2015,241(11).

Ling Xiaozheng, Lu Haozhong, Li Qifeng, et al. Experimental study on the inhibitory effect of Tubacin on the growth of glioma cells. Chinese Journal of Neurosurgery, 2016,32(5).

Zhang Wenbin, Wang Yao, Jiao Fangzhou, et al. Research progress of histone deacetylase 6 in related diseases. Journal of Difficult Diseases, 2019.

Ma Lin, Liu Wei. The therapeutic effect of effective ingredients and their compatibility of traditional Chinese medicine on experimental rheumatoid arthritis. Liaoning Journal of Traditional Chinese Medicine, 2015.

Zhou Yongbin, Zhang Yanzhong, Chen Boyi, et al. Progress in epigenetics of cholangiocarcinoma. World's Latest Medical Information Digest, 2017.

Yu Wei, Han Jingdong. Immunosuppression induced by brain-specific HDAC6 knockdown improves aging performance in Drosophila melanogaster. Phenomics, 2022.

Qi Jiancheng. The effect of salicin on the lifespan of Drosophila melanogaster and its mechanism exploration. Master's thesis of Sichuan Agricultural University, 2019.

Nawrocki ST, Carew JS, Maclean KH, et al. Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA. Blood,2008.

Ting Zhu, Deming Zhao,Zhiqi Song,et al.HDAC6 alleviates prion peptide- mediated neuronal death via modulating PI3K-Akt-mTOR pathway. Neurobiology of Aging,2015.

Simon D,Herva ME, Benitez MJ,et al.Dysfunction of the PI3K-Akt-GSK-3 pathway is a common feature in cell culture and in vivo models of prion disease.Neuropathol Appl Neurobiol, 2014.